Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 5, 2013, Pages 1416-1426

  Uskokovic̈, Vuk ^a   Desai, Tejal A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

calcium phosphate; drug delivery; hydroxyapatite; nanoparticles; solubility

Indexed keywords

BOVINE SERUM ALBUMINS; CALCIUM PHOSPHATE NANOPARTICLES; CALCIUM PYROPHOSPHATE; DRUG RELEASE KINETICS; MONOCALCIUM PHOSPHATES; MULTI-FUNCTIONAL MATERIALS; SMALL ORGANIC MOLECULES; SMALL-MOLECULE DRUGS;

AGGLOMERATION; ANTIBIOTICS; CALCIUM PHOSPHATE; DEGRADATION; DRUG DELIVERY; HYDROXYAPATITE; KINETICS; MOLECULES; PHYSISORPTION; SOLUBILITY;

NANOPARTICLES;

BOVINE SERUM ALBUMIN; CALCIUM PHOSPHATE; CALCIUM PYROPHOSPHATE; FLUORESCEIN; HYDROXYAPATITE; NANOPARTICLE;

ADSORPTION; ANTIBIOTIC THERAPY; ARTICLE; BILE COMPOSITION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; DEGRADATION; DESICCATION; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; KINETICS; OSTEOMYELITIS; PARTICLE SIZE; POWDER; PRECIPITATION; STOICHIOMETRY; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; CALCIUM PHOSPHATES; DELAYED-ACTION PREPARATIONS; DURAPATITE; HUMANS; NANOPARTICLES; OSTEOMYELITIS;

EID: 84875444574     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34426     Document Type: Article

References (50)

1. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H,. Nanomedicine-Challenge and perspectives. Angew Chem Int Ed 2009; 48: 872-897.
2. Uskokovic V, Drofenik M,. Synthesis of materials within reverse micelles. Surf Rev Lett 2005; 12: 239-277.
3. Uskokovic V, Uskokovic DP,. Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agents. J Biomed Mat Res B 2011; 96B: 152-191.
4. Del Pozo JL, Patel R,. Infection associated with prosthetic joints. New Eng J Med 2009; 361: 787-794.
5. Mouzopoulos G, Kanakaris NK, Kontakis G, Obakponovwe O, Townsend R, Giannoudis PV,. Management of bone infections in adults: The surgeon's and microbiologist's perspectives. Injury 2011; 42: S18-S23.
6. Cunha BA,. Osteomyelitis in elderly patients. Clin Infect Dis 2002; 35: 287-293.
7. Kretlow JD, Young S, Klouda L, Wong M, Mikos AG,. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 2009; 21: 3368-3393.
8. Dorozhkin SV,. Biphasic, triphasic and multiphasic calcium orthophosphates. Acta Biomater 2012; 8: 963-977.
9. Guo D, Xu K, Han Y,. The in situ synthesis of biphasic calcium phosphate scaffolds with controllable compositions, structures, and adjustable properties. J Biomed Mater Res A 2009; 88A: 43-52.
10. Daculsi G, Legeros RZ, Nery E, Lynch K, Kerebel B,. Transformation of biphasic calcium phosphate ceramics in vivo: Ultrastructural and physicochemical characterization. J Biomed Mater Res 1989; 23: 883-894.
11. Lukic M, Stojanovic Z, Škapin SD, Macek-Kržmanc M, Mitric M, Markovic S, Uskokovic D,. Dense fine-grained BCP bioceramics designed by two-step sintering. J Eur Ceram Soc 2011; 31: 19-27.
12. Kundu B, Soundrapandian C, Nandi SK, Mukherjee P, Dandapat N, Roy S, Datta BK, Mandal TK, Basu D, Bhattacharya RN,. Systematic approach to treat chronic osteomyelitis through ceftriaxone-sulbactam impregnated porous β-tri calcium phosphate localized delivery system. Ceram Int 2012; 38: 1533-1548.
13. Dorozhkin SV,. Calcium orthophosphates in nature, biology and Medicine. Materials 2009; 2: 399-498.
14. Combes C, Rey C,. Amorphous calcium phosphates. Acta Biomater 2010; 6: 3362-3378.
15. Magalhaes MCF, Marques PAAP, Correia RN,. Calcium and magnesium phosphates: Normal and pathological mineralization. In:, Königsberger E, Königsberger L, editors. Biomineralization-Medical Aspects of Solubility. New York: Wiley-Blackwell; 2007. p 71-123.
16. 7. Acta Crystallogr 1966; 21: 942-948.
17. Markovic S, Veselinovic L, Lukic MJ, Karanovic L, Bracko I, Ignjatovic N, Uskokovic D,. Synthetical bone-like and biological hydroxyapatites. Biomed Mater 2011; 6: 045005.
18. Larsen MJ,. Ion Products and Solubility of Calcium Phosphates. Denmark: Royal Dental College; 2001.
19. Tabakovic A, Kester M, Adair JH,. Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012; 4: 96-112.
20. Epple M, Ganesan K, Heumann R, Klesing J, Kovtun A, Neumann S, Sokolova V,. Application of calcium phosphate nanoparticles in biomedicine. J Mater Chem 2010; 20: 18-23.
21. Ginebra MP, Traykova T, Planell JA,. Calcium phosphate cements as bone drug delivery systems: A review. J Control Release 2006; 113: 102-110.
22. Bose S, Tarafder S,. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review. Acta Biomater 2012; 8: 1401-1421.
23. Verron E, Khairoun I, Guicheux J, Bouler JM,. Calcium phosphate biomaterials as bone drug delivery systems: A review. Drug Discov Today 2010; 15: 547-552.
24. Dasgupta S, Bandyopadhyay A, Bose S,. Reverse micelle-mediated synthesis of calcium phosphate nanocarriers for controlled release of bovine serum albumin. Acta Biomater 2009; 5: 3112-3121.
25. Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusunose T, Toyonaga T, Hamada Y, Takahashi J,. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 2004; 25: 3807-3812.
26. Lee JS, Suarez-Gonzalez D, Murphy WL,. Mineral coatings for temporally controlled delivery of multiple proteins. Adv Mater 2011; 23: 4279-4284.
27. Elliott JC,. Structure and chemistry of the apatites and other calcium orthophosphates. Amsterdam, The Netherlands: Elsevier; 1994.
28. Arellano-Jiménez MJ, García-García R, Reyes-Gasga J,. Synthesis and hydrolysis of octacalcium phosphate and its characterization by electron microscopy. J Phys Chem Solids 2009; 70: 390-395.
29. Lukic MJ, Veselinovic Lj, Stojanovic Z, Macek-Kržmanc M, Bracko I, Škapin SD, Markovic S, Uskokovic D,. Peculiarities in sintering behavior of Ca-deficient hydroxyapatite nanopowders. Mater Lett 2012; 68: 331-335.
30. Hodge HC, LeFevre ML, Bale WF,. Chemical and X-ray diffraction studies of calcium phosphates. Ind Eng Chem Anal Ed 1938; 10: 156-161.
31. Sadat-Shojai M, Khorasani MT, Jamshidi A,. Chemical precipitation of hydroxyapatite nanoparticles-A Taguchi experimental design approach. Mat Chem Phys. Forthcoming
32. Kibalczyc W, Zielenkiewicz A, Zielenkiewicz W,. Calorimetric investigations of calcium phosphate precipitation in relation to solution composition and temperature. Thermochim Acta 1988; 131: 47-55.
33. Mahapatra PP, Mishra H, Chickerur NS,. Solubility of hydroxyapatite and related thermodynamic data. Thermochim Acta 1982; 52: 333-336.
34. 2O. Biomaterials 1997; 18: 915-921.
35. Narasaraju TSB, Phebe DE,. Some physico-chemical aspects of hydroxylapatite. J Mater Sci 1996; 31: 1-21.
36. Pan HB, Darvell BW,. Calcium phosphate solubility: the need for reevaluation. Cryst Growth Des 2009; 9: 639-645.
37. Levinskas GJ, Neuman WF,. The solubility of bone mineral. J Phys Chem 195; 59: 164-168.
38. Kirkham J, Firth A, Vernals D, Boden N, Robinson C, Shore RC, Brookes SJ, Aggeli A,. Physico-chemical properties of crystal surfaces in matrix-mineral interactions during mammalian biomineralisation. Curr Opin Colloid Interface Sci 2002; 7: 124-132.
39. Hole BB, Keller DS, Burry WM, Schwarz JA,. Surface energetics of bone mineral and synthetic hydroxyapatite using inverse gas chromatography. J Chromatogr B 2011; 879: 1847-1850.
40. Santos EA, Farina M, Soares GA, Anselme K,. Surface energy of hydroxyapatite and β-TCP ceramics driving serum protein adsorption and osteoblast adhesion. J Mater Sci Mater Med 2007; 19: 2307-2316.
41. Engel E, Del Valle S, Aparicio C, Altankov G, Asin L, Planell JA, Ginebra MP,. Discerning the role of topography and ion exchange in cell response of bioactive tissue engineering scaffolds. Tissue Eng A 2008; 14: 1341-1351.
42. Boyan BD, Lossdörfer S, Wang L, Zhao G, Lohmann CH, Cochran DL, Schwartz Z,. Osteoblasts generate an osteogenic microenvironment on surfaces with rough microtopographies. Eur Cell Mater 2003; 6: 22-27.
43. Wang Y, Zhang S, Zeng X, Cheng K, Qian M, Weng W,. In vitro behavior of fluoridated hydroxyapatite coatings in organic-containing simulated body fluid. Mater Sci Eng C 2007; 27: 244-250.
44. Mavropoulos E, Costa AM, Costa LT, Achete CA, Mello A, Granjeiro JM, Rossi AM,. Adsorption and bioactivity studies of albumin onto hydroxyapatite surface. Colloids Surf B: Biointerfaces 2011; 83: 1-9.
45. Mazin AL,. Hydroxyapatite thin-layer chromatography of nucleic acid. Mol Biol (Mosk) 1977; 11: 477-498.
46. Fargues PC, Bailly M, Grevillot G,. Adsorption of BSA and hemoglobin on hydroxyapatite support: Equilibria and multicomponent dynamic adsorption. Adsorption 1998; 4: 5-16.
47. Besarab A, DeGuzman A, Swanson JW,. Effect of albumin and free calcium concentrations on calcium binding in vitro. J Clin Pathol 1981; 34: 1361-1367.
48. Mueller B, Zacharias M, Rezwan K,. Bovine serum albumin and lysozyme adsorption on calcium phosphate particles. Adv Eng Mater 2010; 12: B53-B61.
49. Leonhardt H, Gordon L, Livingston, R,. Acid-base equilibriums of fluorescein and 2′,7′-dichlorofluorescein in their ground and fluorescent states. J Phys Chem 1971; 75: 245-249.
50. Bernards DA, Desai TA,. Nanotemplating of biodegradable polymer membranes for constant-rate drug delivery. Adv Mater 2010; 22: 2358-2362.